Download Full Volume - United States Renal Data System

AINCIDENCE OF REPORTED ESRD
Reference section A
Table A.7 A.7 (continued)
Incidence of of reported ESRD, by by primary diagnosis: all patients
1999-2003
1999-2003
combined,
combined,
by
by
detailed
detailed
primary
primary
diagnosis
diagnosis
300
Total Counts
Percent
COLUMN PERCENT Patients White Black N Am Asian White Black N Am Asian
All ESRD (reference) 484,998 315,360 138,749 5,632 16,950 100.0 100.0 100.0 100.0
Diabetes 215,733 139,620 59,957 4,142 8,057 44.6 43.4 73.6 47.7
Type I, juvenile type 20,518 15,269 4,403 214 369 4.9 3.2 3.8 2.2
Type II, adult-onset or unspecified type 195,215 124,351 55,554 3,928 7,688 39.7 40.2 69.8 45.5
Glomerulonephritis 41,097 27,370 10,147 425 2,314 8.7 7.4 7.6 13.7
Focal glomerulosclerosis, focal GN 11,037 6,422 4,088 68 313 2.0 3.0 1.2 1.9
Membranous nephropathy 2,181 1,555 521 18 56 0.5 0.4 0.3 0.3
Membranoproliferative GN, types I & II 1,665 1,218 320 25 72 0.4 0.2 0.4 0.4
IgA nephropathy, Berger's disease 3,661 2,751 263 64 500 0.9 0.2 1.1 3.0
IgM nephropathy 423 314 44 * 57 0.1 . 0.1 0.3
Rapidly progressive GN 1,642 1,326 220 20 49 0.4 0.2 0.4 0.3
Goodpasture's Syndrome 579 528 36 * * 0.2 . 0.1 .
Post infectious GN, SBE 443 363 61 * * 0.1 . 0.1 0.1
Glomerulonephritis (GN) 18,170 11,945 4,331 203 1,207 3.8 3.1 3.6 7.2
Other proliferative GN 1,296 948 263 12 44 0.3 0.2 0.2 0.3
Secondary GN/vasculitis 10,412 6,449 3,339 102 337 2.1 2.4 1.8 2.0
Lupus erythematosus (SLE nephritis) 5,301 2,316 2,551 50 256 0.7 1.8 0.9 1.5
Polyarteritis 253 205 39 * * 0.1 . 0.1 .
Wegeners granulomatosis 1,261 1,160 68 * 12 0.4 . 0.1 0.1
Henoch-Schonlein syndrome 164 139 17 * * . . 0.1 .
Vasculitis and its derivatives 1,097 947 96 20 21 0.3 0.1 0.4 0.1
Scleroderma 840 662 147 * 14 0.2 0.1 0.1 0.1
Hemolytic uremic syndrome 755 580 144 * 11 0.2 0.1 0.1 0.1
Nephropathy from heroin /related abuse 213 81 127 . * . 0.1 . .
Secondary GN, other 528 359 150 * 12 0.1 0.1 0.1 0.1
Interstitial nephritis/pyelonephritis 17,582 14,319 2,438 108 466 4.6 1.8 1.9 2.8
Chronic pyelonephritis, reflux neph. 2,231 1,913 187 23 64 0.6 0.1 0.4 0.4
Analgesic abuse 955 785 130 * 23 0.3 0.1 0.1 0.1
Nephropathy caused by other agents 2,954 2,437 425 16 43 0.8 0.3 0.3 0.3
Nephrolithiasis, obstruction, gouty 6,116 4,839 958 29 188 1.5 0.7 0.5 1.1
Nephrocalcinosis 316 260 36 * 11 0.1 . . 0.1
Chronic interstitial nephritis 4,074 3,295 588 30 118 1.1 0.4 0.5 0.7
Acute interstitial nephritis 936 790 114 * 19 0.3 0.1 0.1 0.1
Hypertensive/large vessel disease 130,704 77,174 47,283 488 4,229 24.6 34.3 8.7 25.1
Hypertension (no primary renal disease) 117,439 64,883 46,587 441 4,066 20.7 33.7 7.8 24.1
Renal artery stenosis or occlusion 9,213 8,450 578 29 110 2.7 0.4 0.5 0.7
Cholesterol emboli, renal emboli 4,052 3,841 118 18 53 1.2 0.1 0.3 0.3
Cystic/hereditary/congenital diseases 15,206 12,508 1,966 85 370 4.0 1.4 1.5 2.2
Polycystic kidneys, adult (dominant) 10,722 8,913 1,352 40 267 2.8 1.0 0.7 1.6
Polycystic kidneys, infantile (recessive) 225 179 26 * * 0.1 . 0.1 .
Medullary cystic, including nephronophthisis 222 187 19 * 10 0.1 . . 0.1
Alport's, other hereditary/familial disease 1,048 912 84 * 31 0.3 0.1 0.1 0.2
Tuberous sclerosis 167 130 29 * * . . . .
Cystinosis 81 66 * * * . . . .
Primary oxalosis 38 32 * * * . . . .
Fabrys disease 83 78 * . . . . . .
Congenital nephrotic syndrome 289 209 56 * 12 0.1 . . 0.1
Drash syndrome, mesangial sclerosis 42 30 * . * . . . .
Congenital obstructive uropathy 1,245 971 201 15 19 0.3 0.1 0.3 0.1
Renal hypoplasia, dysplasia 914 707 143 11 19 0.2 0.1 0.2 0.1
Prune belly syndrome 130 94 33 * * . . . .
Neoplasms/tumors 10,094 7,894 1,901 50 143 2.5 1.4 0.9 0.8
Renal or urological neoplasms 2,846 2,282 494 12 24 0.7 0.4 0.2 0.1
Multiple myeloma 5,390 4,077 1,149 25 90 1.3 0.8 0.4 0.5
Light chain nephropathy 631 514 98 * 10 0.2 0.1 0.1 0.1
Amyloidosis 1,227 1,021 160 * 19 0.3 0.1 0.2 0.1
Miscellaneous conditions 21,301 13,772 6,803 100 310 4.4 4.9 1.8 1.8
Complication post bone marrow/other txp 684 599 63 * * 0.2 . 0.1 0.1
Sickle cell disease/anemia or trait 521 31 485 * * . 0.4 . .
AIDS nephropathy 4,258 336 3,837 * * 0.1 2.8 0.1 .
Traumatic/surgical loss of kidney(s) 527 427 85 . * 0.1 0.1 . .
Hepatorenal syndrome 1,205 987 148 25 24 0.3 0.1 0.4 0.1
Tubular necrosis (no recovery) 8,124 6,607 1,243 44 115 2.1 0.9 0.8 0.7
Post-partum failure, other renal disorders 5,982 4,785 942 23 145 1.5 0.7 0.4 0.9
Etiology uncertain 19,646 14,206 4,213 127 654 4.5 3.1 2.3 3.9
Missing 3,223 2,048 702 * 70 0.7 0.5 0.1 0.4
The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
*Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.